LumaSleep is Nyx Therapeutics' first product concept: a novel sleep-support medicine being developed for the New Zealand market.
LumaSleep is currently in development and is not yet available for sale. Any future launch will be subject to applicable regulatory requirements.
A differentiated sleep-support medicine concept.
Designed for manufacturer collaboration and quality documentation.
Built toward scalable New Zealand supply.
Developed with a quality and regulatory pathway first.
We welcome conversations with manufacturing, regulatory and clinical partners.